Axim Biotechnologies, Inc. – ‘8-K’ for 3/17/20 – ‘EX-2.1’

On:  Wednesday, 3/18/20, at 9:24pm ET   ·   As of:  3/19/20   ·   For:  3/17/20   ·   Accession #:  1078782-20-186   ·   File #:  0-54296

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Form 8K Current Report                              HTML     25K 
 2: EX-2.1      Exhibit 2.1 Share Exchange Agreement, Dated as of   HTML     10K 
                March 17, 2020 by and Among Axim Biotechnologies,                
                Inc., Sapphire Biotech, Inc. and Its Stockholders                
 3: EX-10.1     Exhibit 10.1 Form of Lock-Up Agreement              HTML      6K 
 4: EX-99.1     Exhibit 99.1 March 18, 2020, Press Release          HTML     12K 
                Announcing the Share Exchange                                    

‘EX-2.1’   —   Exhibit 2.1 Share Exchange Agreement, Dated as of March 17, 2020 by and Among Axim Biotechnologies, Inc., Sapphire Biotech, Inc. and Its Stockholders

This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]